Gene therapy and peripheral nerve repair: A perspective

Frontiers in Molecular Neuroscience

Volumn 8, Issue JULY, 2015, Pages

  Hoyng, Stefan A ^a,b   de Winter, Fred ^a,b   Tannemaat, Martijn R ^a,b   Blits, Bas ^c   Malessy, Martijn J A ^a,b   Verhaagen, Joost ^a,d  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIQURE   (Netherlands)

^d VU Amsterdam   (Netherlands)

Author keywords

Adeno associated viral vector; Gene therapy; Lentiviral vector; Neurosurgery; Schwann cell

Indexed keywords

LENTIVIRUS VECTOR; NERVE GROWTH FACTOR; PARVOVIRUS VECTOR;

ANATOMICAL CONCEPTS; ARTICLE; AUTOGRAFT; CLINICAL TRIAL (TOPIC); GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; IMPLANTATION; NERVE STUMP; NERVE SURGERY; NONHUMAN; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; SAFETY; SCHWANN CELL; SURAL NERVE;

EID: 84940979385     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2015.00032     Document Type: Article

References (95)

1. Allodi, I., Mecollari, V., González-Pérez, F., Eggers, R., Hoyng, S., Verhaagen, J., et al. (2014). Schwann cells transduced with a lentiviral vector encoding Fgf-2 promote motor neuron regeneration following sciatic nerve injury. Glia 62, 1736- 1746. doi: 10.1002/glia.22712
2. Allodi, I., Udina, E., and Navarro, X. (2012). Specificity of peripheral nerve regeneration: interactions at the axon level. Prog. Neurobiol. 98, 16- 37. doi: 10.1016/j.pneurobio.2012.05.005
3. Al-Majed, A. A., Brushart, T. M., and Gordon, T. (2000). Electrical stimulation accelerates and increases expression of BDNF and trkB mRNA in regenerating rat femoral motoneurons. Eur. J. Neurosci. 12, 4381- 4390. doi: 10.1111/j.1460-9568.2000.01341.x
4. Andrews, M. R., Czvitkovich, S., Dassie, E., Vogelaar, C. F., Faissner, A., Blits, B., et al. (2009). Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J. Neurosci. 29, 5546- 5557. doi: 10.1523/jneurosci.0759-09.2009
5. Arthur-Farraj, P. J., Latouche, M., Wilton, D. K., Quintes, S., Chabrol, E., Banerjee, A., et al. (2012). c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75, 633- 647. doi: 10.1016/j.neuron.2012.06.021
6. Aspalter, M., Vyas, A., Feiner, J., Griffin, J., Brushart, T., and Redett, R. (2009). Modification of Schwann cell gene expression by electroporation in vivo. J. Neurosci. Methods 176, 96- 103. doi: 10.1016/j.jneumeth.2008. 08.035
7. Bareyre, F. M., Garzorz, N., Lang, C., Misgeld, T., Büning, H., and Kerschensteiner, M. (2011). In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration. Proc. Natl. Acad. Sci. U S A 108, 6282- 6287. doi: 10.1073/pnas.10152 39108
8. Bartus, R. T., Baumann, T. L., Siffert, J., Herzog, C. D., Alterman, R., Boulis, N., et al. (2013). Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology 80, 1698- 1701. doi: 10.1212/wnl.0b013e3182904faa
9. Blits, B., Carlstedt, T. P., Ruitenberg, M. J., de Winter, F., Hermens, W. T., Dijkhuizen, P. A., et al. (2004). Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp. Neurol. 189, 303- 316. doi: 10.1016/j.expneurol.2004.05.014
10. Brushart, T. M. (2011). Nerve Repair. New York: Oxford University Press.
11. Brushart, T. M., Jari, R., Verge, V., Rohde, C., and Gordon, T. (2005). Electrical stimulation restores the specificity of sensory axon regeneration. Exp. Neurol. 194, 221- 229. doi: 10.1016/j.expneurol.2005.02.007
12. Bucher, T., Colle, M. A., Wakeling, E., Dubreil, L., Fyfe, J., Briot-Nivard, D., et al. (2013). scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease. Hum. Gene Ther. 24, 670- 682. doi: 10.1089/hum.2012.218
13. Cesana, D., Ranzani, M., Volpin, M., Bartholomae, C., Duros, C., Artus, A., et al. (2014). Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo. Mol. Ther. 22, 774- 785. doi: 10.1038/mt.2014.3
14. Cheever, T. R., Berkley, D., Braun, S., Brown, R. H., Byrne, B. J., Chamberlain, J. S., et al. (2015). Perspectives on best practices for gene therapy programs. Hum. Gene Ther.26, 127- 133. doi: 10.1089/hum.2014.147
15. Chen, X., Astary, G. W., Mareci, T. H., and Sarntinoranont, M. (2011). In vivocontrast-enhanced MR imaging of direct infusion into rat peripheral nerves. Ann. Biomed. Eng. 39, 2823- 2834. doi: 10.1007/s10439-011-0362-x
16. Chu, T. H., Wang, L., Guo, A., Chan, V. W., Wong, C. W., and Wu, W. (2012). GDNF-treated acellular nerve graft promotes motoneuron axon regeneration after implantation into cervical root avulsed spinal cord. Neuropathol. Appl. Neurobiol. 38, 681- 695. doi: 10.1111/j.1365-2990.2012. 01253.x
17. Das, A. T., Klaver, B., Centlivre, M., Harwig, A., Ooms, M., Page, M., et al. (2008). Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution. Retrovirology 5:44. doi: 10.1186/1742- 4690-5-44
18. De Palma, M., Montini, E., Santoni de Sio, F. R., Benedicenti, F., Gentile, A., Medico, E., et al. (2005). Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 105, 2307- 2315. doi: 10.1182/blood-2004- 03-0798
19. Dijkhuizen, P. A., Pasterkamp, R. J., Hermens, W. T., de Winter, F., Giger, R. J., and Verhaagen, J. (1998). Adenoviral vector-mediated gene delivery to injured rat peripheral nerve. J. Neurotrauma 15, 387- 397. doi: 10.1089/neu.1998.15.387
20. Dirren, E., Towne, C. L., Setola, V., Redmond, D. E. Jr., Schneider, B. L., and Aebischer, P. (2014). Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord. Hum. Gene Ther. 25, 109- 120. doi: 10.1089/hum.2013.021
21. Eggers, R., de Winter, F., Hoyng, S. A., Roet, K. C., Ehlert, E. M., Malessy, M. J., et al. (2013). Lentiviral vector-mediated gradients of GDNF in the injured peripheral nerve: effects on nerve coil formation, Schwann cell maturation and myelination. PLoS One8:e71076. doi: 10.1371/journal.pone.0071076
22. Eggers, R., Hendriks, W. T., Tannemaat, M. R., van Heerikhuize, J. J., Pool, C. W., Carlstedt, T. P., et al. (2008). Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots. Mol. Cell. Neurosci. 39, 105- 117. doi: 10.1016/j.mcn.2008.05.018
23. Eggers, R., Tannemaat, M. R., Ehlert, E. M., and Verhaagen, J. (2010). A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbar ventral root avulsion and implantation. Exp. Neurol.223, 207- 220. doi: 10.1016/j.expneurol.2009.07.021
24. Esaki, S., Kitoh, J., Katsumi, S., Goshima, F., Kimura, H., Safwat, M., et al. (2011). Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury. Gene Ther. 18, 1063- 1069. doi: 10.1038/gt.2011.57
25. Federa. (2011). Human tissue and medical research: code of conduct for responsible use. Available online at: http://www.federa.org/
26. Felberbaum, R. S. (2015). The baculovirus expression vector system: a commercial manufacturing platform for viral vaccines and gene therapy vectors. Biotechnol. J. 10, 702- 714. doi: 10.1002/biot.201400438
27. Ferreira, V., Petry, H., and Salmon, F. (2014). Immune responses to AAV-vectors, the glybera example from bench to bedside. Front. Immunol. 5:82. doi: 10.3389/fimmu.2014.00082
28. Geller, A. I., and Breakefield, X. O. (1988). A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 241, 1667- 1669. doi: 10.1126/science.2843986
29. Glorioso, J. C., and Fink, D. J. (2009). Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol. Ther. 17, 13- 18. doi: 10.1038/mt.2008.213
30. Godinho, M. J., Teh, L., Pollett, M. A., Goodman, D., Hodgetts, S. I., Sweetman, I., et al. (2013). Immunohistochemical, ultrastructural and functional analysis of axonal regeneration through peripheral nerve grafts containing Schwann cells expressing BDNF, CNTF or NT3. PLoS One 8:e69987. doi: 10.1371/journal.pone.0069987
31. Gordon, T., Amirjani, N., Edwards, D. C., and Chan, K. M. (2010). Brief post-surgical electrical stimulation accelerates axon regeneration and muscle reinnervation without affecting the functional measures in carpal tunnel syndrome patients. Exp. Neurol.223, 192- 202. doi: 10.1016/j.expneurol.2009.09.020
32. Gordon, T., Brushart, T. M., and Chan, K. M. (2008). Augmenting nerve regeneration with electrical stimulation. Neurol. Res. 30, 1012- 1022. doi: 10.1179/174313208x362488
33. Gordon, T., Tyreman, N., and Raji, M. A. (2011). The basis for diminished functional recovery after delayed peripheral nerve repair. J. Neurosci. 31, 5325- 5334. doi: 10.1523/jneurosci.6156-10.2011
34. Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J., and Jude Samulski, R. (2013). Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 20, 450- 459. doi: 10.1038/gt.2012.101
35. Grosios, K., and Pañeda, A. (2013). Gene therapy for AIP. Pan European Networks: Science and Technology. Available online at: www.paneuropeannetworks.com
36. Haastert, K., Lipokatic, E., Fischer, M., Timmer, M., and Grothe, C. (2006). Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol. Dis. 21, 138- 153. doi: 10.1016/j.nbd.2005.06.020
37. Haastert, K., Ying, Z., Grothe, C., and Gómez-Pinilla, F. (2008). The effects of FGF-2 gene therapy combined with voluntary exercise on axonal regeneration across peripheral nerve gaps. Neurosci. Lett. 443, 179- 183. doi: 10.1016/j.neulet.2008.07.087
38. Haastert-Talini, K. (2011). Gene therapy approaches for neuroregeneration. Curr. Gene Ther. 11:74. doi: 10.2174/156652311794940809
39. Haastert-Talini, K., Schmitte, R., Korte, N., Klode, D., Ratzka, A., and Grothe, C. (2011). Electrical stimulation accelerates axonal and functional peripheral nerve regeneration across long gaps. J. Neurotrauma 28, 661- 674. doi: 10.1089/neu.2010.1637
40. Hastie, E., and Samulski, R. J. (2015). Adeno-associated virus at 50: a golden anniversary of discovery, research and gene therapy success-a personal perspective.Hum. Gene Ther. 26, 257- 265. doi: 10.1089/hum. 2015.025
41. Hendriks, W. T., Eggers, R., Carlstedt, T. P., Zaldumbide, A., Tannemaat, M. R., Fallaux, F. J., et al. (2007). Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune "stealth" transgene. Restor. Neurol. Neurosci. 25, 585- 599.
42. Hermens, W. T., and Verhaagen, J. (1997). Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats. Hum. Gene Ther. 8, 1049- 1063. doi: 10.1089/hum.1997. 8.9-1049
43. Homs, J., Ariza, L., Pagès, G., Udina, E., Navarro, X., Chillón, M., et al. (2011). Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration. Gene Ther. 18, 622- 630. doi: 10.1038/gt.2011.7
44. Homs, J., Pagès, G., Ariza, L., Casas, C., Chillón, M., Navarro, X., et al. (2014). Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy. Mol. Ther. Methods Clin. Dev. 1:7. doi: 10.1038/mtm.2013.7
45. Hordeaux, J., Dubreil, L., Deniaud, J., Iacobelli, F., Moreau, S., Ledevin, M., et al. (2015). Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats. Gene Ther. 22, 316- 324. doi: 10.1038/gt. 2014.121
46. Hoyng, S. A., De Winter, F., Gnavi, S., de Boer, R., Boon, L. I., Korvers, L. M., et al. (2014a). A comparative morphological, electrophysiological and functional analysis of axon regeneration through peripheral nerve autografts genetically modified to overexpress BDNF, CNTF, GDNF, NGF, NT3 or VEGF. Exp. Neurol. 261, 578- 593. doi: 10.1016/j.expneurol.2014.08.002
47. Hoyng, S. A., Gnavi, S., de Winter, F., Eggers, R., Ozawa, T., Zaldumbide, A., et al. (2014b). Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve. Gene Ther. 21, 549- 557. doi: 10.1038/gt.2014.22
48. Hoyng, S. A., De Winter, F., Gnavi, S., van Egmond, L., Attwell, C., Tannemaat, M. R., et al. (2015). Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1 to 9 and lentiviral vectors. Gene Ther. doi: 10.1038/gt.2015.47 [Epub ahead of print].
49. Hu, X., Cai, J., Yang, J., and Smith, G. M. (2010). Sensory axon targeting is increased by NGF gene therapy within the lesioned adult femoral nerve. Exp. Neurol. 223, 153- 165. doi: 10.1016/j.expneurol.2009.08.025
50. Huang, L., Quan, X., Liu, Z., Ma, T., Wu, Y., Ge, J., et al. (2015). c-Jun gene-modified schwann cells: upregulating multiple neurotrophic factors and promoting neurite outgrowth. Tissue Eng. Part A 21, 1409- 1421. doi: 10.1089/ten.tea.2014.0416
51. Hung, H. A., Sun, G., Keles, S., and Svaren, J. (2015). Dynamic regulation of Schwann cell enhancers after peripheral nerve injury. J. Biol. Chem. 290, 6937- 6950. doi: 10.1074/jbc.m114.622878
52. Jazwa, A., Florczyk, U., Jozkowicz, A., and Dulak, J. (2013). Gene therapy on demand: site specific regulation of gene therapy. Gene 525, 229- 238. doi: 10.1016/j.gene.2013.03.093
53. Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., et al. (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369, 2097- 2105. doi: 10.1016/s0140-6736(07)60982-9
54. Keller, A. F., Gravel, M., and Kriz, J. (2009). Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia 57, 1130- 1142. doi: 10.1002/glia.20836
55. Kotterman, M. A., and Schaffer, D. V. (2014). Engineering adeno-associated viruses for clinical gene therapy. Nat. Rev. Genet. 15, 445- 451. doi: 10.1038/nrg3742
56. Krauze, M. T., Mcknight, T. R., Yamashita, Y., Bringas, J., Noble, C. O., Saito, R., et al. (2005a). Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res. Brain Res. Protoc. 16, 20- 26. doi: 10.1016/j.brainresprot.2005.08.003
57. Krauze, M. T., Saito, R., Noble, C., Bringas, J., Forsayeth, J., Mcknight, T. R., et al. (2005b). Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Exp. Neurol. 196, 104- 111. doi: 10.1016/j.expneurol.2005.07.009
58. Leone, P., Janson, C. G., Bilaniuk, L., Wang, Z., Sorgi, F., Huang, L., et al. (2000). Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann. Neurol. 48, 27- 38. doi: 10.1002/1531-8249(200007)48:1<27::aid-ana6>3.0.co;2-6
59. Leone, P., Shera, D., Mcphee, S. W., Francis, J. S., Kolodny, E. H., Bilaniuk, L. T., et al. (2012). Long-term follow-up after gene therapy for canavan disease. Sci. Transl. Med.4:165ra163. doi: 10.1126/scitranslmed.3003454
60. Li, Q., Ping, P., Jiang, H., and Liu, K. (2006). Nerve conduit filled with GDNF gene-modified Schwann cells enhances regeneration of the peripheral nerve. Microsurgery26, 116- 121. doi: 10.1002/micr.20192
61. Markusic, D., and Seppen, J. (2010). Doxycycline regulated lentiviral vectors.Methods Mol. Biol. 614, 69- 76. doi: 10.1007/978-1-60761-533-0_4
62. Mason, M. R., Ehlert, E. M., Eggers, R., Pool, C. W., Hermening, S., Huseinovic, A., et al. (2010). Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol. Ther. 18, 715- 724. doi: 10.1038/mt.2010.19
63. Mason, M. R., Tannemaat, M. R., Malessy, M. J., and Verhaagen, J. (2011). Gene therapy for the peripheral nervous system: a strategy to repair the injured nerve?Curr. Gene Ther. 11, 75- 89. doi: 10.2174/156652311794940764
64. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24, 687- 696. doi: 10.1038/nbt1216
65. Nathwani, A. C., Reiss, U. M., Tuddenham, E. G., Rosales, C., Chowdary, P., Mcintosh, J., et al. (2014). Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N. Engl. J. Med. 371, 1994- 2004. doi: 10.1056/NEJMoa1407309
66. Ossevoort, M., Zaldumbide, A., Cramer, S. J., Van Der Voort, E. I., Toes, R. E., and Hoeben, R. C. (2006). Characterization of an immuno 'stealth' derivative of the herpes simplex virus thymidine-kinase gene. Cancer Gene Ther. 13, 584- 591. doi: 10.1038/sj.cgt.7700925
67. Pajenda, G., Hercher, D., Marton, G., Pajer, K., Feichtinger, G. A., Maleth, J., et al. (2014). Spatiotemporally limited BDNF and GDNF overexpression rescues motoneurons destined to die and induces elongative axon growth. Exp. Neurol. 261, 367- 376. doi: 10.1016/j.expneurol.2014.05.019
68. Parikh, P., Hao, Y., Hosseinkhani, M., Patil, S. B., Huntley, G. W., Tessier-Lavigne, M., et al. (2011). Regeneration of axons in injured spinal cord by activation of bone morphogenetic protein/Smad1 signaling pathway in adult neurons. Proc. Natl. Acad. Sci. U S A 108, E99- 107. doi: 10.1073/pnas.1100426108
69. Passini, M. A., Bu, J., Richards, A. M., Treleaven, C. M., Sullivan, J. A., O'riordan, C. R., et al. (2014). Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Hum. Gene Ther. 25, 619- 630. doi: 10.1089/hum.2014.011
70. Peel, A. L., Zolotukhin, S., Schrimsher, G. W., Muzyczka, N., and Reier, P. J. (1997). Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 4, 16- 24. doi: 10.1038/sj.gt.3300358
71. Pereira Lopes, F. R., Martin, P. K., Frattini, F., Biancalana, A., Almeida, F. M., Tomaz, M. A., et al. (2013). Double gene therapy with granulocyte colony-stimulating factor and vascular endothelial growth factor acts synergistically to improve nerve regeneration and functional outcome after sciatic nerve injury in mice. Neuroscience230, 184- 197. doi: 10.1016/j.neuroscience.2012.10.025
72. Pleticha, J., Heilmann, L. F., Evans, C. H., Asokan, A., Samulski, R. J., and Beutler, A. S. (2014a). Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs. Mol. Pain 10:54. doi: 10.1186/1744-8069-10-54
73. Pleticha, J., Jeng-Singh, C., Rezek, R., Zaibak, M., and Beutler, A. S. (2014b). Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons. Mol. Cell. Neurosci. 60, 72- 80. doi: 10.1016/j.mcn.2014.04.004
74. Pleticha, J., Maus, T. P., Christner, J. A., Marsh, M. P., Lee, K. H., Hooten, W. M., et al. (2014c). Minimally invasive convection-enhanced delivery of biologics into dorsal root ganglia: validation in the pig model and prospective modeling in humans. Technical note. J. Neurosurg. 121, 851- 858. doi: 10.3171/2014.6.jns132364
75. Pleticha, J., Maus, T. P., Jeng-Singh, C., Marsh, M. P., Al-Saiegh, F., Christner, J. A., et al. (2013). Pig lumbar spine anatomy and imaging-guided lateral lumbar puncture: a new large animal model for intrathecal drug delivery. J. Neurosci. Methods 216, 10- 15. doi: 10.1016/j.jneumeth.2013.03.006
76. Rafii, M. S., Baumann, T. L., Bakay, R. A., Ostrove, J. M., Siffert, J., Fleisher, A. S., et al. (2014). A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimers Dement. 10, 571- 581. doi: 10.1016/j.jalz.2013.09.004
77. Ratliff, J. K., and Oldfield, E. H. (2001). Convection-enhanced delivery in intact and lesioned peripheral nerve. J. Neurosurg. 95, 1001- 1011. doi: 10.3171/jns.2001.95.6.1001
78. Richardson, R. M., Kells, A. P., Rosenbluth, K. H., Salegio, E. A., Fiandaca, M. S., Larson, P. S., et al. (2011). Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol. Ther. 19, 1048- 1057. doi: 10.1038/mt.2011.11
79. Salmon, F., Grosios, K., and Petry, H. (2014). Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera(R)). Expert Rev. Clin. Pharmacol. 7, 53- 65. doi: 10.1586/17512433.2014.852065
80. Samaranch, L., Salegio, E. A., San Sebastian, W., Kells, A. P., Bringas, J. R., Forsayeth, J., et al. (2013). Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum. Gene Ther. 24, 526- 532. doi: 10.1089/hum.2013.005
81. Santosa, K. B., Jesuraj, N. J., Viader, A., Macewan, M., Newton, P., Hunter, D. A., et al. (2013). Nerve allografts supplemented with schwann cells overexpressing glial-cell-line-derived neurotrophic factor. Muscle Nerve 47, 213- 223. doi: 10.1002/mus.23490
82. Scott, L. J. (2015). Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency. Drugs 75, 175- 182. doi: 10.1007/s40265-014-0339-9
83. Shakhbazau, A., Kawasoe, J., Hoyng, S. A., Kumar, R., Van, M. J., Verhaagen, J., et al. (2012). Early regenerative effects of NGF-transduced Schwann cells in peripheral nerve repair. Mol. Cell. Neurosci. 50, 103- 112. doi: 10.1016/j.mcn.2012.04.004
84. Shen, J., Wang, H. Y., Chen, J. Y., and Liang, B. L. (2006). Morphologic analysis of normal human lumbar dorsal root ganglion by 3D MR imaging. AJNR Am. J. Neuroradiol. 27, 2098- 2103.
85. Snyder, B. R., Gray, S. J., Quach, E. T., Huang, J. W., Leung, C. H., Samulski, R. J., et al. (2011). Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum. Gene Ther. 22, 1129- 1135. doi: 10.1089/hum.2011.008
86. Tannemaat, M. R., Boer, G. J., Verhaagen, J., and Malessy, M. J. (2007). Genetic modification of human sural nerve segments by a lentiviral vector encoding nerve growth factor. Neurosurgery 61, 1286- 1294. doi: 10.1227/01.neu.0000306108.78044.a2
87. Tannemaat, M. R., Eggers, R., Hendriks, W. T., De Ruiter, G. C., Van Heerikhuize, J. J., Pool, C. W., et al. (2008). Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur. J. Neurosci. 28, 1467- 1479. doi: 10.1111/j.1460-9568.2008.06452.x
88. Tardieu, M., Zerah, M., Husson, B., De Bournonville, S., Deiva, K., Adamsbaum, C., et al. (2014). Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I/II trial. Hum. Gene Ther. 25, 506- 516. doi: 10.1089/hum.2013.238
89. Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., et al. (2005). A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11, 551- 555. doi: 10.1038/nm1239
90. Verge, V. M., Andreassen, C. S., Arnason, T. G., and Andersen, H. (2014). Mechanisms of disease: role of neurotrophins in diabetes and diabetic neuropathy. Handb. Clin. Neurol. 126, 443- 460. doi: 10.1016/B978-0-444-53480-4.00032-1
91. Wong, J. N., Olson, J. L., Morhart, M. J., and Chan, K. M. (2015). Electrical stimulation enhances sensory recovery: a randomized control trial. Ann. Neurol. 77, 996- 1006. doi: 10.1002/ana.24397
92. Wright, M. C., Mi, R., Connor, E., Reed, N., Vyas, A., Alspalter, M., et al. (2014). Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration.J. Neurosci. 34, 1689- 1700. doi: 10.1523/jneurosci.3822- 13.2014
93. Yáñez-Muñoz, R. J., Balaggan, K. S., Macneil, A., Howe, S. J., Schmidt, M., Smith, A. J., et al. (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12, 348- 353. doi: 10.3410/f.1007629. 373945
94. Yin, Y., Manoury, B., and Fåhraeus, R. (2003). Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301, 1371- 1374. doi: 10.1126/science.1088902
95. Zaldumbide, A., and Hoeben, R. C. (2008). How not to be seen: immune-evasion strategies in gene therapy. Gene Ther. 15, 239- 246. doi: 10.1038/sj.gt.3303082